Page 26 - Sciences Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Robeco Institutional Asset Management B.V. boosted its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 727.8% during the fourth quarter, HoldingsChannel reports. The fund owned 42,026 shares of the medical research company’s stock after purchasing an additional 36,949 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Exact Sciences […]

Regent Peak Wealth Advisors LLC cut its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 4.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,604 shares of the medical research company’s stock after selling 578 shares during the […]

Exact Sciences Co. (NASDAQ:EXAS – Get Rating) EVP Sarah Condella sold 1,000 shares of Exact Sciences stock in a transaction on Monday, May 1st. The stock was sold at an average price of $63.78, for a total transaction of $63,780.00. Following the completion of the sale, the executive vice president now owns 86,401 shares of […]

Exact Sciences Co. (NASDAQ:EXAS – Get Rating) EVP Sarah Condella sold 1,000 shares of Exact Sciences stock in a transaction on Monday, May 1st. The shares were sold at an average price of $63.78, for a total value of $63,780.00. Following the completion of the sale, the executive vice president now owns 86,401 shares in […]

Exact Sciences Co. (NASDAQ:EXAS – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the fourteen brokerages that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year target price […]